FDA OKs Mepolizumab for Younger Children With Severe Asthma

Share this post

Nucala is the first biologic approved in the US for children aged 6 to 11 years with severe eosinophilic asthma.
News Alerts

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.


Share this post

Be the first to comment

Leave a Reply